Dishman Carbogen Amcis Hits Intraday Low Amid Price Pressure

4 hours ago
share
Share Via
Dishman Carbogen Amcis experienced a notable intraday decline, touching a low of Rs 245.65, reflecting a 7.18% reduction in value. This downturn contrasts with the broader market's modest gains, highlighting immediate pressures on the stock within the Pharmaceuticals & Biotechnology sector.



Intraday Performance and Market Context


On 18 Dec 2025, Dishman Carbogen Amcis recorded a significant intraday low of Rs 245.65, marking a 7.18% fall from its previous close. This movement represents a reversal after five consecutive sessions of gains, signalling a shift in short-term momentum. The stock's performance today underperformed its sector by approximately 6.7%, while the Sensex showed a marginal positive change of 0.03%, trading at 84,588.28 points after a flat opening.


The Sensex remains close to its 52-week high of 86,159.02, currently about 1.86% below that peak. It is trading above its 50-day moving average, which itself is positioned above the 200-day moving average, indicating a generally bullish trend for the broader market. Mid-cap stocks led the market with a slight gain of 0.05% on the BSE Mid Cap index, contrasting with the pressure seen on Dishman Carbogen Amcis.



Technical Indicators and Moving Averages


Dishman Carbogen Amcis's price today remains above its 5-day and 20-day moving averages, suggesting some short-term support. However, it is trading below its 50-day, 100-day, and 200-day moving averages, which may indicate resistance levels and a more cautious medium- to long-term outlook. The stock's inability to sustain gains above these longer-term averages could be contributing to the current price pressure.


Such a pattern often reflects a consolidation phase or a pause in upward momentum, especially after a series of gains. The recent decline interrupts a five-day positive streak, signalling a potential reassessment by market participants.




Quarter after quarter, this Small Cap from the Lifestyle sector delivers without fail! Just added to our Reliable Performers with proven staying power. Stability meets growth here beautifully.



  • - Consistent quarterly delivery

  • - Proven staying power

  • - Stability with growth


See the Consistent Performer →




Comparative Performance Over Various Timeframes


Examining Dishman Carbogen Amcis's performance across different periods reveals a mixed trend. Over the past week, the stock has shown an 11.89% gain, outperforming the Sensex, which declined by 0.28% in the same timeframe. However, the one-month performance shows a slight decline of 1.01%, marginally below the Sensex's 0.11% fall.


Looking further back, the three-month period reflects a 14.59% decline for the stock, contrasting with the Sensex's 1.88% gain. The one-year and year-to-date figures also show the stock lagging behind the benchmark, with declines of 13.26% and 9.39% respectively, while the Sensex posted gains of 5.48% and 8.24% over the same durations.


Longer-term data presents a more positive picture, with the stock rising 163.61% over three years, significantly outpacing the Sensex's 37.89% gain. However, over five years, the stock's 63.54% increase trails the Sensex's 80.10%, and the ten-year performance shows no change for Dishman Carbogen Amcis compared to the Sensex's 231.43% rise.



Sector and Industry Positioning


Dishman Carbogen Amcis operates within the Pharmaceuticals & Biotechnology sector, an area that has seen varied performance in recent sessions. Despite the sector's overall resilience, the stock's underperformance today highlights specific pressures that may be influencing its price action. The divergence from sector trends suggests that factors unique to the company or its immediate market environment are at play.


Market capitalisation grading places the company at a moderate level within its peer group, reflecting its standing as a small-cap entity. This status often entails greater volatility and sensitivity to market sentiment shifts, which may explain the sharper intraday movements compared to broader indices.




Considering Dishman Carbogen Amcis ? Wait! SwitchER has found potentially better options in Pharmaceuticals & Biotechnology and beyond. Compare this small-cap with top-rated alternatives now!



  • - Better options discovered

  • - Pharmaceuticals & Biotechnology + beyond scope

  • - Top-rated alternatives ready


Compare & Switch Now →




Market Sentiment and Immediate Pressures


The intraday decline in Dishman Carbogen Amcis reflects a shift in market sentiment, with investors appearing cautious after a period of sustained gains. The stock's fall contrasts with the broader market's steady performance, suggesting that company-specific factors or profit-taking activity may be influencing trading behaviour.


Price pressure today may also be linked to the stock's position relative to key moving averages. While short-term averages provide some support, the resistance posed by longer-term averages could be limiting upward momentum. This dynamic often results in increased volatility as market participants weigh the stock's near-term prospects.


Overall, the stock's performance today underscores the challenges faced by small-cap stocks in maintaining momentum amid broader market fluctuations. The divergence from sector and index trends highlights the importance of monitoring technical indicators and market sentiment closely.



Summary of Key Metrics


To summarise, Dishman Carbogen Amcis's intraday low of Rs 245.65 represents a 7.18% decline, underperforming its sector by 6.7%. The stock reversed a five-day upward trend and remains below its 50-day, 100-day, and 200-day moving averages. While the broader market and mid-cap indices showed modest gains, the stock's performance today reflects immediate price pressures and a cautious market stance.






{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News